Spotlight on ALS Research and Q&A | ALS Quebec

We are pleased to invite you to our next Spotlight on ALS Research and Q&A session, which will take place virtually on Zoom on June 9th from 6 p.m. to 8 p.m.

Leading amyotrophic lateral sclerosis (ALS) researchers and clinicians will shed light on their current clinical studies. Presentations will be followed by a question-and-answer period. Dr. Richard Robitaille, Ph.D., Full Professor of Department of Neuroscience at Université de Montréal, will be hosting the meeting.

Please send your questions in advance by email to kbusch@sla-quebec.ca

  • Date: Tuesday, June 9th, 2026
  • Time: 6 p.m. to 8 p.m.
  • Location: This meeting will be held on Zoom


Meet our panel of researchers and clinicians:

Dr. Richard Robitaille, Ph.D.
Full Professor, Department of Neuroscience, Université de Montréal
Board Member of ALS Quebec
Member of the SMAC, ALS Canada
Dr. Gary Armstrong, Ph.D.
Associate Professor and Killam Research Scholar
Department of Neurology and Neurosurgery, McGill University
Dr. Angela Genge, M.D.
Professor of Neurology, McGill University
Director CIM and clinical research McGill University Health Center Research Institute
Director ALS Clinic The Neuro
Director Access ALS
Dr. Geneviève Matte, M.D.C.M., FRCPC
Director, ALS and Motor Neuron Disease Clinic, CHUM
Researcher, CRCHUM
Associate Professor, Department of Neuroscience, Université de Montréal
Co-Chair of the Canadian ALS Research Network (CALS)
Dr. Kessen Patten, Ph.D.
Full Professor, Institut National de la Recherche Scientifique (INRS), Centre Armand-Frappier Santé Biotechnologie, Anna Sforza Djoukhadjian Research Chair in ALS.
Dr. Vincent Picher-Martel, M.D., Ph.D.
Neurologist, CHU de Québec
Assistant Professor, Université Laval

Dr. Silvia Pozzi, Ph.D.
Assistant Professor, Department of Psychiatry and Neuroscience, Université Laval
Canada Research Chair in Central and Peripheral Cellular Networks in ALS

Dr. Chantelle Sephton, Ph.D.
Professor, Department of Psychiatry and Neuroscience, Université Laval
Co-Chair of the SMAC
Board Member of ALS Canada
Member of the Scientific Advisory Committee of ALS Quebec

On the agenda

Coming soon


Thanks to our sponsors


Practical information and accessibility

N.B. If you have speech difficulties due to ALS or are simply less comfortable in a group, know that you are welcome to participate via the chat function in Zoom.

If you are not familiar with Zoom, or with online communications, please consult our Zoom guides on our website.

For further questions, contact Kate Busch, our Programs and Services Coordinator.


Share this article.